Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients

Clinical trial NCT04723706 · COMPLETED

Trial details

NCT number: NCT04723706
Sponsor: Henry Ford Health System
Status: COMPLETED
Study type: OBSERVATIONAL

Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)

Start date: 2021-03-19
Primary completion: 2023-12-02
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.